Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics

Oral Oncology

Volumn 40, Issue 6, 2004, Pages 604-610

  Nishimoto, Ines Nobuko ^a   Pinheiro, Nidia Alice ^b   Rogatto, Silvia Regina ^c   Carvalho, André Lopes ^a   Simpson, Andrew J ^b   Caballero, Otávia Luisa ^b   Kowalski, Luiz Paulo ^a  

^a Ctro Tratamento Pesquisa Hosp D   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cancer; CCND1 polymorphism; Risk factor; UADT; Upper aerodigestive system

Indexed keywords

CYCLIN D1;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIGESTIVE SYSTEM CANCER; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 1842477455     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.12.009     Document Type: Article

References (30)

1. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer. 37(8 Suppl):2001;S4-S66.
2. Franceschi S., Bidoli E., Herrero R., Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 36:2000;106-115.
3. Wunsch-Filho V. The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol. 38:2002;737-746.
4. Franco E.L., Kowalski L.P., Oliveira B.V.et al. Risk factors for oral cancer in Brazil: a case-control study. Int. J. Cancer. 43:1989;992-1000.
5. Copper M.P., Jovanovic A., Nauta J.J.P.et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch. Otholaringol. 121:1995;157-160.
6. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 36:2000;256-263.
7. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
8. Muller D., Millon R., Velten M.et al. Amplification of 11q13DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur. J. Cancer. 33:1997;2203-2210.
9. Mathias C., Janhke V., Jones P.W.et al. Cyclin D1, Gluthathione S-transferase, and Cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol. Biomarkers Prev. 8:1999;815-823.
10. Gleich L.L., Salamone F.N. Molecular genetics of head and neck cancer. Cancer Control. 9:2002;369-378.
11. Sawa H., Ohshima T.A., Ukita H.et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 16:1998;1701-1712.
12. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come age. Cell. 79:1994;573-582.
13. Akerval J., Borg A., Dictor M.et al. Chromosomal translocations involving 11q13 contribute to cyclin D1 in squamous cell carcinoma of the head and neck. Int. J. Oncol. 20:2002;45-52.
14. Donnellan R., Chetty R. Cyclin D1 and human neoplasia (Reviews). Mol. Pathol. 51:1998;1-7.
15. Betticher D.C., Thatcher N., Altermatt H.J., Hoban P., Ryder W.D.J., Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 11:1995;1005-1011.
16. Kong S., Amos C.I., Luthra R., Lynch P.M., Levin B., Frazier M.L. Effects of cyclin D1 polymorphism on age of onset of hereditary nompolyposis colorectal cancer. Cancer Res. 60:2000;249-252.
17. Zheng Y., Shen H., Sturgis E.M.et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 22:2001;1195-1199.
18. Kong S., Wei Q., Amos C.I.et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J. Natl. Cancer Inst. 93:2001;1106-1108.
19. Porter T.R., Richards F.M., Houlston R.S.et al. Contribution of cyclin D1(CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene. 21:2002;1928-1933.
20. Wang L., Habuchi T., Takahashi T.et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis. 23:2002;257-264.
21. Underhill P.A., Jin L., Lin A.A.et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res. 7:1997;996-1005.
22. Breslow N.E., Day N.E. Statistical methods in cancer research: the analysis of case-control studies. 1980;IARC Scientific Publications, Lyon. nr. 32.
23. Callender T., el-Naggar A.K., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 74:1994;152-158.
24. Fioretti F., Bossetti C., Tavani A., Franceschi S., La Vechia C. Risk factors for oral and pharyngeal cancer in never smokers. Oral Oncol. 35:1999;375-378.
25. Talamini R., La Vecchia C., Levi F., Conti E., Favero A., Franceschi S. Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and nondrinkers who smoke tobacco. J. Natl. Cancer Inst. 90:1998;1901-1903.
26. Wacholder S., Silverman D.T., McLaughlin J.K., Mandel J.S. Selection of controls in case-control studies. II. Types of controls. Am. J. Epidemiol. 135:1992;1029-1041.
27. Yu C., Lu W., Tan W.et al. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 12:2003;176.
28. Betticher D.C., Heighway J., Hasleton P.S.et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br. J. Cancer. 73:1996;294-300.
29. Wang L., Habuchi T., Mitsumori K.et al. Increased risk of prostate cancer associated withAA genotype of cyclin D1 gene A870G polymorphism. Int. J. Cancer. 103:2003;116-120.
30. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 2. Chromosomal aberrations. Oral Oncol. 36:2000;311-327.